DermBiont, Inc.
Biotechnology ResearchView the employees at
DermBiont, Inc.-
Laurent Bouillaut VP Discovery and Translational Research
-
Greater Boston
-
Top 10%
Michaela Sliney Project Management, HR & Recruiting at DermBiont, Inc.-
Greater Boston
-
Rising Star
Ravi Pandrapragada Head of CMC, Small Molecule Tech Operations-
Clarksburg, Maryland, United States
-
Top 10%
Noopur Gupta Bioprocess CMC Scientist at DermBiont, Inc.-
Shrewsbury, Massachusetts, United States
-
Rising Star
Naho K. Clinical Trial Manager with 5 years in clinical operations-
San Francisco Bay Area
-
Rising Star
Overview
DermBiont’s mission is to become the world’s leading precision dermatology company developing and commercializing targeted topical therapeutics that treat, cure, and prevent diseases. The company aims to impact the root causes of skin diseases through the development of targeted small molecule therapeutics with well-defined mechanisms of action and biotherapeutics that repair an imbalance of the microbiome. The company’s targeted topical therapeutics pipeline includes SM-020 for the treatment of seborrheic keratosis, SM-030 for the treatment of hyperpigmentation disorders of the skin, and DBI-001 & DBI-002 for the treatment of atopic dermatitis, tinea pedis, and onychomycosis. For more information, please visit www.dermbiont.com.
-